Abstract:To control graft-versus-host disease (GVHD) following allogeneic hematopoietic stem cell (HSC) transplantation while maintaining the graft antileukemic effects of donor T cells, a suicide gene encoding the herpes simplex virus thymidine kinase (HSV-TK) enzyme was introduced ex vivo via a retroviral vector into donor T cells. Although previous clinical trials showed that it was an efficient tool for controlling GVHD, the gene transduction process of donor T lymphocytes may influence the immunocompetence of the T cells. In the current study, we investigated the impact that the gene manipulation in vitro had on the phenotype and functionality of human donor T lymphocytes. We engineered human T lymphocytes with HSV-TK and puromycin resistance gene with a retrovirus vector and analyzed the phenotype change of gene modified cells with flowcytometry. The secretion of gamma-interferon and interleukin-4 of T lymphocyte were detected with enzyme-linked immunospot(ELIPOT)assays. We also analyzed the lytic activity of T cells against allogeneic targets. The result showed that the number of TK gene transduced T lymphocyte was sufficient for clinical use. There was an inversion of the CD4+/CD8+ ratio in the gene modified T cell (GMC) compared with the fresh peripheral blood lymphocytes (PBLs). In addition, the GMCs showed a higher expression of HLA-DR and had more antigen-experienced cells than did the PBLs. In ELIPOT assays, significantly less gamma-interferon secretion by GMCs was observed compared to PBLs (50 vs. 115 spots/well-3×104cells, p<0.05). The results also showed that IL-4-secreting cell frequencies was similar in GMCs and in PBLs (19.3 vs. 20.3 spots/well-3×104cells, p>0.05). After stimulated by allogeneic PBMCs, the GMCs effectors showed a significant reduction in lytic activity against allogeneic targets in contrast with PBL. In conclusion, HSV-TK gene transduction and selection procedure can change the phenotype and functions of human T lymphocyte. The gene modified T lymphocytes still showed biological activities although lower than those of PBLs.

Hytk Gene Expression Promoted by PSA Promoters in Prostate Carcinoma Cell Lines

Retrovirus-mediated HSV1-tk Gene Therapy for Androgen-Independent Prostate Cancer

Vaccination with A Dna Vaccine Based on Human Psca and Hsp70 Adjuvant Enhances the Antigen-Specific Cd8(+) T-Cell Response and Inhibits the Psca(+) Tumors Growth in Mice

Gene Therapy with HSV1-sr39TK/GCV Exhibits a Stronger Therapeutic Efficacy Than HSV1-TK/GCV in Rat C6 Glioma Cells

[Retroviral-Mediated Transfer of a Hygromycin Phosphotransferase-Thymidine Kinase Fusion Gene into Human Bladder Carcinoma Cell].

Rerovirus Mediated Hsv-Tk Gene Transfer Can Influence The Function Of Human T-Lymphocyte

Adenovirus-mediated herpes simplex virus thymidine kinase gene therapy for experimental prostate cancer

Enhancing Hsp70-Shrna Transfection In 22rv1 Prostate Cancer Cells By Combination Of Sonoporation, Liposomes And Htert/Cmv Chimeric Promoter

[Experimental Study on Human Pulmonary Adenocarcinoma Cell A549 Transfected with HSV₁-TK Gene in Vitro and in Vivo].

The Anti-Tumor Effect of GM-CSF-tk Fusion Gene in Human Neuroblastoma Cell Line SH-SY5Y

Construction of Retroviral Vector Carrying HSV-tk Gene under Control of Human AFP Enhancer Core Sequence and Human Pgk Promotor.

Targeted Treatment of Hepatoma Using HSV-TK Suicide Gene with the PBI-SUR-TK Vector

Optimization of Adenoviral Vectors to Direct Highly Amplified Prostate-Specific Expression for Imaging and Gene Therapy

A Study on the Activity of Htert Promoter Related Tumor Targeting Gene on Colon Cancer Cell Line DLD-1

Functionality of Androgen Receptor-Based Gene Expression Imaging in Hormone Refractory Prostate Cancer

Construction and Identification of Recombinant Vectors Carrying Herpes Simplex Virus Thymidine Kinase and Cytokine Genes Expressed in Gastric Carcinoma Cell Line SGC7901

Construction of two plasmids mediating suicide gene for treatment of hepatocellular carcinomain vitro

Suicide gene therapy for hepatocellular carcinoma cells by survivin promoter-driven expression of the herpes simplex virus thymidine kinase gene.

Inhibitory effect of ultrasound microbubbles carrying HSV_1-TK gene combined with ganciclovir on prostate cancer cells

[The Effect of HSV-tk/GCV on Hepatic Specific Damage Driven by Murine ALB Promoter/enhancer].

Construction of a Golgi Protein 73 Modified Liposome That Mediates HSVtk Induced Liver Cancer Cell Apoptosis